Further, ATP1A3, which was recently shown to be altered in EVs purified from AD patient biofluid samples [54], was exclusively found in the GDE2-eFLAG EVs, along with the presynaptic protein, SYP, which regulates synaptic vesicle release [62]. This evidence concerns the gene ATP1A3 and Alzheimer disease.